Quantum Cyber (QUCY) EBITDA Margin (2022 - 2023)
Quantum Cyber (QUCY) posted EBITDA Margin of 3068.71% for Q4 2023, up 1.17% sequentially from 3104.9% in Q3 2023, and up 127159.0% YoY from N/an in Q4 2022.
Quantum Cyber (QUCY) EBITDA Margin (2022 - 2023) Analysis & Trends
Quantum Cyber has reported EBITDA Margin for 2 years, with the latest figure at 3068.71% in Q4 2023.
- Quarterly EBITDA Margin rose 127159.0% year-over-year to 3068.71% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 2975.47% (up 201513.0% YoY) and the FY2025 annual result came in at 3004.97%, down 90504.0% from the prior year.
- EBITDA Margin rose to 3068.71% in Q4 2023 per QUCY's latest filing, from 3104.9% in the prior quarter.
- Over five years, EBITDA Margin peaked at 2593.94% in Q1 2023 and troughed at 5657.13% in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Quantum Cyber | 16.67 Mn | 11.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -3,068.71% |
| Sep 30, 2023 | -3,104.90% |
| Jun 30, 2023 | -3,183.87% |
| Mar 31, 2023 | -2,593.94% |
| Dec 31, 2022 | -4,340.30% |
| Sep 30, 2022 | -5,657.13% |
| Jun 30, 2022 | -4,989.88% |
| Mar 31, 2022 | -5,599.92% |